azacitidine "stada" 25 mg/ml pulver til injektionsvæske, suspension
stada arzneimittel ag - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
azacitidine "zentiva" 25 mg/ml pulver til injektionsvæske, suspension
zentiva k.s. - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
azacitidin "sun" 25 mg/ml pulver til injektionsvæske, suspension
sun pharmaceutical industries europe bv - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
azacitidin "tillomed" 25 mg/ml pulver til injektionsvæske, suspension
tillomed pharma gmbh - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
azacitidine zentiva 25 mg/ml pulver til injektionsvæske, suspension
orifarm a/s - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
azacitidine mylan
mylan ireland limited - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiske midler - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.
azacitidine "ever pharma" 25 mg/ml pulver til injektionsvæske, suspension
ever valinject gmbh - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
etraga 25 mg/ml pulver til injektionsvæske, suspension
stada arzneimittel ag - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml
binocrit
sandoz gmbh - epoetin alfa - anemia; kidney failure, chronic - antianemiske præparater - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e. hjerte-kar-status, præ-eksisterende anæmi ved start af kemoterapi).
epoetin alfa hexal
hexal ag - epoetin alfa - anemia; kidney failure, chronic; cancer - antianemiske præparater - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. behandling af anæmi og til nedsættelse af transfusion hos voksne patienter, der modtager kemoterapi for massive tumorer, malignt lymfom eller myelomatose, og ved risiko for transfusion som vurderet af patientens almene status (e. hjerte-kar-status, præ-eksisterende anæmi ved start af kemoterapi).